Reports Q2 revenue $34.862M, consensus $33.53B. Chief Executive Officer Rosalind Brewer said: "WBA exited a solid second quarter with acceleration in February, adding to our confidence in driving strong growth in the second half of the year. With the closing of VillageMD’s acquisition of Summit Health, WBA is now one of the largest players in primary care, with best-in-class assets across the care continuum. Both Walgreens and Boots are performing well by delivering compelling value to consumers, playing a critical role as community health destinations, and successfully navigating a challenging environment. We will continue to take bold actions to create sustainable long-term shareholder value."
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on WBA:
- Walgreens Boots Alliance Inc. Earnings Update: Did it Beat Estimate Forecasts?
- Walgreens In the Green on Q2 Beat
- Notable companies reporting before tomorrow’s open
- Walgreens Boots Alliance price target lowered to $43 from $45 at Barclays
- Walgreens Boots Alliance Inc. (WBA) Q2 Earnings Cheat Sheet
Questions or Comments about the article? Write to editor@tipranks.com